CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Guangdong Hybribio Biotech Co Ltd Company Snapshot
Guangdong Hybribio Biotech Co Ltd operates within the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Guangdong Hybribio Biotech Co Ltd with three other companies in this sector in China: Beijing Leadman Biochemistry Co Ltd (2017 sales of 575.98 million Chinese Renmimbi [US$83.72 million] of which 100% was Biological products industry), Tellgen Corp (302.89 million Chinese Renmimbi [US$44.02 million] of which 94% was Reagent Income), and Getein Biotech Inc (488.58 million Chinese Renmimbi [US$71.02 million] of which 99% was In-vitro diagnostics).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Guangdong Hybribio Biotech Co Ltd
  Stock Performance Chart for Guangdong Hybribio Biotech Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 14.72
(Figures in Chinese Renmimbi)
1 Week -0.3%   13 Weeks -3.0%  
4 Weeks -12.1%   52 Weeks -53.9%  
 
Guangdong Hybribio Biotech Co Ltd Key Data:
  Ticker: 300639 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 479,085,120
(Year Ending Jan 2018).
Employees: 1,012
  Currency: Chinese Renmimbi Market Cap: 2,649,217,280
  Fiscal Yr Ends: December Shares Outstanding: 179,974,000
  Share Type: A GU Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.